News
The hard problem: innovation for high prevalence, chronic diseases of ageing Last year, IQVIA predicted that 2022 would be the crunch year for Alzheimer’s therapies: it is with a sense of déjà ...
Jam out to eight tracks in class.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback